Health Canada issues safety information on Vioxx, Celebrex, Bextra & Mobicox
Health Canada with their statement on the COX-2’s, adding Mobic to the warnings. Could be a harbinger of the FDA’s position.
ADVERTISEMENT
More in Uncategorized
Past Week
-
Your doctor saved your life but won’t return your call [PODCAST]
-
Why bipolar II is not just a milder version of bipolar I
-
Opt-out states and physician-led anesthesia care explained
-
Why artificial intelligence displacement threatens medical specialties
-
A family legacy inspiring advocacy in neurodevelopmental care
-
How minor injuries lead to flesh-eating bacteria in rural Nigeria
-
Past 6 Months
-
I Googled my own name and a corporate clinic I’ve never worked at appeared [PODCAST]
-
Rethinking the role of family physicians vs. specialists
-
How corporate health care ruined the medical profession
-
Clinicians are failing at value-based care because no one taught them the system [PODCAST]
-
A humorous parody of medical specialties and the modern patient
-
Pharmacy closures threaten our entire public health system
-
Recent Posts
-
Physician burnout is not a failure of resilience
-
How a clinical trial changed the way I see Mother’s Day
-
What no one tells you about fertility, from a doctor
-
Why bipolar II is not just a milder version of bipolar I
-
Rebuilding patient trust when medical advice is resisted
-
Women physicians’ health is paying the price of medicine
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
